§ Mrs. Anne Campbell
To ask the Secretary of State for Health on what basis the therapeutic areas mentioned in the proposed limited listing of NHS drugs have been selected; and what consultation has taken place in the selection of the therapeutic areas in the limited listing.
§ Dr. Mawhinney
The categories were chosen because they cover a range of products at varying price levels and therefore offered scope for savings while enabling all real clinical needs to continue to be met. No consultations took place, because the basic structure of the select list scheme has not changed. It will be for the independent advisory committee on national health service drugs to give advice on whether particular products should be removed from prescription under the NHS.